PRINCIPAL SECURITIES, INC.

Broker-Dealer

Position in NVS — Novartis AG

CIK 12600 DES MOINES, IA

Position in NVS

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$4,345,375

-$460,751 QoQ

Shares Held

27,727

-11.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#291

of 1,603 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

PRINCIPAL SECURITIES, INC. holds $102,042,410 across 14 Drug Manufacturers - General names. NVS ranks #8 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	23,901	$28,667,578
2	JNJ	Johnson & Johnson	70,522	$17,910,472
3	ABBV	AbbVie Inc.	44,899	$11,298,384
4	MRK	Merck & Co., Inc.	72,897	$9,367,264
5	AMGN	Amgen Inc	19,357	$7,009,556
6	AZN	Astrazeneca PLC	33,467	$6,346,012
7	GILD	Gilead Sciences, Inc.	35,653	$4,504,400
8	NVS	Novartis AG This page	27,727	$4,345,375

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,345,375	27,727	-11.9%	Shares	Sole	2026-08-04
2026-03-31	$4,806,126	31,464	-8.4%	Shares	Sole	2026-05-13
2025-12-31	$4,738,316	34,368	-3.9%	Shares	Sole	2026-02-12
2025-09-30	$4,587,273	35,771	-2.5%	Shares	Sole	2025-11-12
2025-06-30	$4,439,130	36,684	+27.1%	Shares	Sole	2025-08-11
2025-03-31	$3,218,427	28,870	+0.4%	Shares	Sole	2025-04-30
2024-12-31	$2,798,343	28,757	+10.0%	Shares	Sole	2025-01-30
2024-09-30	$3,007,082	26,144	+18.9%	Shares	Sole	2024-10-28
2024-06-30	$2,341,161	21,991	+34.4%	Shares	Sole	2024-07-31
2024-03-31	$1,582,599	16,361	-18.8%	Shares	Sole	2024-05-10
2023-12-31	$2,034,444	20,149	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.